Breast (Apr 2021)

A cost-effectiveness analysis of trastuzumab in Taiwanese patients with stage II-III HER2-positive breast cancer and axillary node metastasis

  • W. Chou,
  • W.-C. Wu,
  • C.-T. Cheng

Journal volume & issue
Vol. 56
pp. S59 – S60

Abstract

Read online

No abstracts available.